Autoimmune astrocytopathy double negative for AQP4‐IgG and GFAP‐IgG: Retrospective research of clinical practice, biomarkers, and pathology
There are unidentified astrocyte antibodies. The manifestations of double-negativity are heterogeneous; nevertheless, the pathology and biomarkers remain consistent with astrocytopathy. Immunotherapy is effective.
Authors
- Shi‐Feng Zhang
- Jiajia Yue
- Sha Liao
- Peihao Lin (ORCID: https://orcid.org/0000-0002-0775-795X)
- Congcong Fu (ORCID: https://orcid.org/0000-0001-6856-5639)
- Wen‐Dong Lai
- Xiaoli Yao (ORCID: https://orcid.org/0000-0003-2613-7956)
- Youming Long (ORCID: https://orcid.org/0000-0002-4004-2948)
- Cong Gao (ORCID: https://orcid.org/0000-0002-5291-5312)
- Ding Liu (ORCID: https://orcid.org/0009-0002-2460-4709)
- Li Huang (ORCID: https://orcid.org/0000-0002-1564-0110)
- Haiyan Yao
- Zhifeng Mao
- Guan‐Yan Lin
- Chun Lian
- Jie Yang
- Bao‐Yi Long
Institutions
- Central South University (CN)
- Sun Yat-sen University (CN)
- Changsha Medical University (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Kingmed Diagnostics (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Guangzhou Eighth People's Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/cns.70042
- Citations
- 20
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 7.38
Funders
- Guangzhou Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province